Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1980

  • Quoted phrase not found.
1.

Acetylcysteine for Patients Requiring Mucous Secretion Clearance: A Review of Clinical Effectiveness and Safety [Internet].

Banerjee S, McCormack S.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jun 14.

2.

Acute exacerbation of idiopathic pulmonary fibrosis: usual interstitial pneumonitis vs. possible usual interstitial pneumonitis pattern.

Cao MS, Sheng J, Wang TZ, Qiu XH, Wang DM, Wang Y, Xiao YL, Cai HR.

Chin Med J (Engl). 2019 Sep 3. doi: 10.1097/CM9.0000000000000422. [Epub ahead of print]

PMID:
31490258
3.

Scientific Papers and Patents on Substances with Unproven Effects. Part 2.

Jargin SV.

Recent Pat Drug Deliv Formul. 2019 Aug 19. doi: 10.2174/1872211313666190819124752. [Epub ahead of print]

PMID:
31424374
4.

Changes in alpha-foetoprotein and Gc-globulin in relation to outcomes in non-acetaminophen acute liver failure.

Singh S, Hynan LS, Rule JA, Lee WM.

Liver Int. 2019 Aug 17. doi: 10.1111/liv.14216. [Epub ahead of print]

PMID:
31421008
5.

The radioprotective effect of N-acetylcysteine against x-radiation-induced renal injury in rats.

Mercantepe T, Topcu A, Rakici S, Tumkaya L, Yilmaz A, Mercantepe F.

Environ Sci Pollut Res Int. 2019 Aug 7. doi: 10.1007/s11356-019-06110-0. [Epub ahead of print]

PMID:
31392607
6.

Comment on "transition to two-bag intravenous acetylcysteine for acetaminophen overdose".

Mullins ME, Yarema MC, Sivilotti MLA, Thompson M, Beuhler MC, Algren DA, Holstege CP.

Clin Toxicol (Phila). 2019 Aug 7:1-3. doi: 10.1080/15563650.2019.1649418. [Epub ahead of print] No abstract available.

PMID:
31389258
8.

[Improved and harmonised laboratory analysis of paracetamol provides safer assessment of poisoning cases].

Nordmark Grass J, Elmgren A, Helander A.

Lakartidningen. 2019 Jul 29;116. pii: FPMA. Swedish.

9.

In Vitro Synergism of Colistin and N-acetylcysteine against Stenotrophomonas maltophilia.

Ciacci N, Boncompagni S, Valzano F, Cariani L, Aliberti S, Blasi F, Pollini S, Rossolini GM, Pallecchi L.

Antibiotics (Basel). 2019 Jul 25;8(3). pii: E101. doi: 10.3390/antibiotics8030101.

10.

Autophagy in Triptolide-Mediated Cytotoxicity in Hepatic Cells.

Wei YM, Luan ZH, Liu BW, Wang YH, Chang YX, Xue HQ, Ren JH.

Int J Toxicol. 2019 Sep/Oct;38(5):436-444. doi: 10.1177/1091581819864518. Epub 2019 Jul 25.

PMID:
31342801
11.

Safety and Efficacy of the SNAP 12-hour Acetylcysteine Regimen for the Treatment of Paracetamol Overdose.

Pettie JM, Caparrotta TM, Hunter RW, Morrison EE, Wood DM, Dargan PI, Thanacoody RH, Thomas SHL, Elamin MEMO, Francis B, Webb DJ, Sandilands EA, Eddleston M, Dear JW.

EClinicalMedicine. 2019 May 2;11:11-17. doi: 10.1016/j.eclinm.2019.04.005. eCollection 2019 May-Jun.

12.

Principal results of a randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with a 12 h regimen of N-acetylcysteine for paracetamol overdose (POP trial).

Morrison EE, Oatey K, Gallagher B, Grahamslaw J, O'Brien R, Black P, Oosthuyzen W, Lee RJ, Weir CJ, Henriksen D, Dear JW; POP Trial Investigators.

EBioMedicine. 2019 Aug;46:423-430. doi: 10.1016/j.ebiom.2019.07.013. Epub 2019 Jul 13.

13.

Evaluation and treatment of acetaminophen toxicity.

Fisher ES, Curry SC.

Adv Pharmacol. 2019;85:263-272. doi: 10.1016/bs.apha.2018.12.004. Epub 2019 Jan 22.

PMID:
31307590
14.

Characteristics and Outcomes of Acetaminophen Overdose and Hepatotoxicity in Thailand.

Pholmoo N, Bunchorntavakul C.

J Clin Transl Hepatol. 2019 Jun 28;7(2):132-139. doi: 10.14218/JCTH.2018.00066. Epub 2019 Jun 14.

15.

Functional and metabolic impairment in cigarette smoke-exposed macrophages is tied to oxidative stress.

Aridgides DS, Mellinger DL, Armstrong DA, Hazlett HF, Dessaint JA, Hampton TH, Atkins GT, Carroll JL, Ashare A.

Sci Rep. 2019 Jul 3;9(1):9624. doi: 10.1038/s41598-019-46045-7.

17.

Intentional or Inadvertent Acetaminophen Overdose-How Lethal It Really Is?

Thusius NJ, Romanowicz M, Bostwick JM.

Psychosomatics. 2019 May 14. pii: S0033-3182(19)30085-4. doi: 10.1016/j.psym.2019.05.001. [Epub ahead of print]

PMID:
31202442
18.

Management of Fulminant Hepatitis B.

Ichai P, Samuel D.

Curr Infect Dis Rep. 2019 Jun 4;21(7):25. doi: 10.1007/s11908-019-0682-9. Review.

PMID:
31165271
19.

Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.

Rogliani P, Matera MG, Page C, Puxeddu E, Cazzola M, Calzetta L.

Respir Res. 2019 May 27;20(1):104. doi: 10.1186/s12931-019-1078-y.

20.

Acetylcysteine-decorated Prussian blue nanoparticles for strong photothermal sterilization and focal infection treatment.

Cai S, Qian J, Yang S, Kuang L, Hua D.

Colloids Surf B Biointerfaces. 2019 Sep 1;181:31-38. doi: 10.1016/j.colsurfb.2019.05.007. Epub 2019 May 7.

PMID:
31121379

Supplemental Content

Loading ...
Support Center